172
Views
8
CrossRef citations to date
0
Altmetric
Hypothesis

The Binary Classification Of Chronic Diseases

Pages 319-333 | Published online: 16 Dec 2019

References

  • Sugimoto MA, Sousa LP, Pinho V, Perretti M, Teixeira MM. Resolution of inflammation: what controls its onset? Front Immunol. 2016;7:160. doi:10.3389/fimmu.2016.0016027199985
  • Sagiv JY, Michaeli J, Assi S, et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015;10(4):562–573. doi:10.1016/j.celrep.2014.12.03925620698
  • Klinker MW, Lundy SK. Multiple mechanisms of immune suppression by B lymphocytes. Mol Med. 2012;18:123–137. doi:10.2119/molmed.2011.0033322033729
  • Perobelli SM, Silva TG, Bonomo A. Neutrophils plasticity: the regulatory interface in various pathological conditions In: Khajah M editor. Role of Neutrophils in Disease Pathogenesis. Intech Open Science Open Min d;2017. doi:10.5772/68130.
  • Zhou L, Lopes JE, Chong MM, et al. TGF-beta- induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORgammat function. Nature. 2008;453(7192):236–240. doi:10.1038/nature06878.18368049
  • Papageorgis P, Stylianopoulos T. Role of TGFβ in regulation of the tumor microenvironment and drug delivery (Review). Int J Oncol. 2015;46(3):933–943. doi:10.3892/ijo.2015.2816.25573346
  • Eruslanov EB, Bhojnagarwala PS, Quatromoni JG, et al. Tumor-associated neutrophils stimulate T cell responses in early-stage human lung cancer. J Clin Invest. 2014;124(12):5466–5480. doi:10.1172/JCI77053.25384214
  • Wu P, Wu D, Ni C, et al. γδT17 cells promote the accumulation and expansion of myeloid-derived suppressor cells in human colorectal cancer. Immunity. 2014;40(5):785–800. doi:10.1016/j.immuni.2014.24816404
  • Kirkbride KC, Blobe GC. Inhibiting the TGF-beta signalling pathway as a means of cancer immunotherapy. Expert Opin Biol Ther. 2003;3:251–261. doi:10.1517/14712598.3.2.251.12662140
  • Kehrl JH, Wakefield LM, Roberts AB, et al. Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med. 1986;163:1037–1050. doi:10.1084/jem.163.5.1037.2871125
  • Dahmani A, Delisle JS. TGF-β in T cell biology:implications for cancer immunotherapy. Cancers (Basel). 2018;10(6):pii: E194. doi:10.3390/cancers10060194.
  • Lee GR. The balance of Th17 versus treg cells in autoimmunity. Int J Mol Sci. 2018;19(3):730. doi:10.3390/ijms19030730.
  • Buckner JH. Mechanisms of impaired regulation by CD4+CD25+FOXP3+regulatory T cells in human autoimmune diseases. Nat Rev Immunol. 2010;10(12):849–859. doi:10.1038/nri2889.21107346
  • Shull MM, Ormsby I, Kier AB, et al. Targeted disruption of the mouse transforming growth factor -β 1 gene results in multifocal inflammatory disease. Nature. 1992;359:693–699. doi:10.1038/359693a0.1436033
  • Dang H, Geiser AG, Letterio JJ, et al. SLE-like autoantibodies and Sjogren’s syndrome-like lymphoproliferation in TGF-β knockout mice. J Immunol. 1995;155:3205–3212.7673733
  • Hashimoto M. Th17 in animal models of rheumatoid arthritis. J Clin Med. 2017;6(7):73. doi:10.3390/jcm6070073.
  • Asquith DL, Miller AM, McInnes IB, Liew FY. Animal models of rheumatoid arthritis. Eur J Immunol. 2009;39(8):2040–2044. doi:10.1002/eji.200939578.19672892
  • Hirahara K, Ghoreschi K, Laurence A, Yang XP, Kanno Y, O’Shea JJ. Signal transduction pathways and transcriptional regulation in Th17 cell differentiation. Cytokine Growth Factor Rev. 2010;21(6):425–434. doi:10.1016/j.cytogfr.2010.10.006.21084214
  • Geng J, Yu S, Zhao H, et al. The transcriptional coactivator TAZ regulates reciprocal differentiation of TH17 cells and Treg cells. Nat Immunol. 2017;18(7):800–812. doi:10.1038/ni.3748.28504697
  • Roychoudhuri R, Hirahara K, Mousavi K, et al. MBACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis. Nature. 2013;498(7455):506–510. doi:10.1038/nature12199.23728300
  • Khorramdelazad H, Hassanshahi G, Nasiri Ahmadabadi B, Kazemi Arababadi M. High serum levels of TGF-β in Iranians with chronic HBV infection. Hepat Mon. 2012;12(11):e7581. doi:10.5812/hepatmon.7581.23346151
  • Nelson DR, Gonzalez-Peralta RP, Qian K, et al. Transforming growth factor-beta 1 in chronic hepatitis C. J Viral Hepat. 1997;4(1):29–35. doi:10.1046/j.1365-2893.1997.00124.x.9031062
  • Moriuchi M, Moriuchi H. Transforming growth factor‐β enhances human T‐cell leukemia virus type I infection. J Med Virol. 2002;67(3):427–430. doi:10.1002/jmv.1007412116037
  • Xu J, Ahmad A, Jones JF, et al. Elevated serum transforming growth factor beta1 levels in Epstein -Barr virus- associated diseases and their correlation with virus-specific immunoglobulin A (IgA) and IgM. J Virol. 2000;74(5):2443–2446. doi:10.1128/JVI.74.5.2443-2446.2000.10666277
  • Yin WY, Lee MC, Huang HB, Lu MC. Increased gene expression of TGF- in peripheral blood mononuclear cells from renal transplant patients with polyomavirus BK viremia. Clin Transplant. 2016;30(4):393–398. doi:10.1111/ctr.12698.26783039
  • Schmidt J, Blum HE, Thimme R. T-cell responses in hepatitis B and C virus infection: similarities and differences. Emerg Microbes Infect. 2013;2(3):e15. doi:10.1038/emi.2013.14.26038456
  • Hao C, Zhou Y, He Y, et al. Imbalance of regulatory T cells and T helper type 17 cells in patients with chronic hepatitis C. Immunology. 2014;143(4):531–538. doi:10.1111/imm.1233024903732
  • Leal FE, Ndhlovu LC, Hasenkrug AM, et al. Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. PLoS Negl Trop Dis. 2013;7(2):e2028. doi:10.1371/journal.pntd.0002028.23409198
  • Futagbi G, Gyan B, Nunoo H, et al. High levels of IL-10 and CD4+CD25hi+ treg cells in endemic burkitt’s lymphoma patients. Biomedicines. 2015;3:224–236. doi:10.3390/biomedicines3030224.28536409
  • Zhang NN, Chen JN, Xiao L, et al. Accumulation mechanisms of CD4(+)CD25(+)FOXP3(+) regulatory T cells in EBV-associated gastric carcinoma. Sci Rep. 2015;20155:18057. doi:10.1038/srep18057.
  • Song D, Li H, Li H, Dai J. Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncol Lett. 2015;10(2):600–606. doi:10.3892/ol.2015.3295.26622540
  • Dowlatshahi M, Huang V, Gehad AE, et al. Tumor-specific T cells in human merkel cell carcinomas: a possible role for tregs and T-cell exhaustion in reducing T-cell responses. J Invest Dermatol. 2013;133:1879–1889. doi:10.1038/jid.2013.75.23419694
  • Lepone LM, Rappocciolo G, Piazza PA, Campbell DM, Jenkins FJ, Rinaldo CR. Regulatory T cell effect on CD8+ T cell responses to human herpesvirus 8 infection and development of kaposi’s sarcoma. AIDS Res Hum Retroviruses. 2017;33(7):668–674. doi:10.1089/AID.2016.0155.28121161
  • Jacqueline C, Tasiemski A, Sorci G, et al. Infections and cancer: the “fifty shades of immunity” hypothesis. BMC Cancer. 2017;17:257. doi:10.1186/s12885-017-3234-4.28403812
  • Serelli-Lee V, Ling KL, Ho C, et al. Persistent Helicobacter pylori specific Th17 responses in patients with past H. pylori infection are associated with elevated gastric mucosal IL-1β. PLoS One. 2012;7(6):e39199. doi:10.1371/journal.pone.0039199.22761739
  • Larussa T, Leone I, Suraci E, Imeneo M, Luzza F. Helicobacter pylori and T Helper Cells: mechanisms of immune escape and tolerance. J Immunol Res 2015 2015 Article ID 981328. doi:10.1155/2015/981328.
  • Kao JY, Zhang M, Miller MJ, et al. Helicobacter pylori immune escape is mediated by dendritic cell-induced Treg skewing and Th17 suppression in mice. Gastroenterology. 2010;138(3):1046–1054. doi:10.1053/j.gastro.2009.11.043.19931266
  • Jang TJ. The number of Foxp3-positivce regulatory T cells is increased in Helicobacter pylori gastritis and gastric cancer. Pathol Res Pract. 2010;206(1):34–38. doi:10.1016/j.prp.2009.07.019.19819643
  • Li N, Xie C, Lu NH. Transforming growth factor-β: an important mediator in Helicobacter pylori-associated pathogenesis. Front Cell Infect Microbiol. 2015;5:77. doi:10.3389/fcimb.2015.00077.26583078
  • Halenius A, Hengel H. Human cytomegalovirus and autoimmune disease. Biomed Res Int. 2014;472978. doi:10.1155/2014/472978.24967373
  • Draborg AH, Duus K, Houen G. Epstein-Barr virus in systemic autoimmune diseases. Clin Dev Immunol. 2013;2013:535738. doi:10.1155/2013/535738.24062777
  • Salloum N, Hussein HM, Jammaz R, Jiche S, Uthman IW, Abdelnoor AM, et al. Epstein-Barr virus DNA modulates regulatory T-cell programming in addition to enhancing interleukin-17A production via Toll-like receptor 9. PLoS One. 2018;13(7):e0200546. doi:10.1371/journal.pone.020054.29995930
  • Walker LSK, von Herrath M. CD4 T cell differentiation in type 1 diabetes. Clin Exp Immunol. 2016;183(1):16–29. doi:10.1111/cei.12672.26102289
  • Crotty S. Follicular helper CD4 T cells (TFH). Annu Rev Immunol. 2011;29:621–663. doi:10.1146/annurev-immunol-031210-101400.21314428
  • Attridge K, Wang CJ, Wardzinski L, et al. IL-21 inhibits T cell IL-2 production and impairs Treg homeostasis. Blood. 2012;119(20):4656–4664. doi:10.1182/blood-2011-10-388546.22442347
  • Filippi CM, von Herrath MG. Viral trigger for type 1 diabetes. Pros and Cons Diabetes. 2008;57(11):2863–2871. doi:10.2337/db07-1023.18971433
  • Long Q, Liao YH, Xie Y, et al. Coxsackievirus B3 directly induced Th17 cell differentiation by inhibiting Nup98 expression in patients with acute viral myocarditis. Front Cell Infect Microbiol. 2016;6:171. doi:10.3389/fcimb.2016.00171.28018858
  • Cunningham MW. Rheumatic fever, autoimmunity, and molecular mimicry: the streptococcal connection. Int Rev Immunol. 2014;33(4):314–329. doi:10.3109/08830185.2014.917411.24892819
  • Wang B, Dileepan T, Briscoe S, et al. Induction of TGF-β1 and TGF-β1–dependent predominant Th17 differentiation by group A streptococcal infection. Proc Natl Acad Sci U S A. 2010;107(13):5937–5942. doi:10.1073/pnas.0904831107.20231435
  • Costalonga M, Cleary PP, Fischer LA, et al. Intranasal bacteria induce Th1 but not Treg or Th2. Mucosal Immunol. 2009;2(1):85–95. doi:10.1038/mi.2008.67.19079337
  • Mukhopadhyay S, Varma S, Mohan Kumar HN, et al. Circulating level of regulatory T cells in rheumatic heart disease: an observational study. Indian Heart J. 2016;68(3):342–348. doi:10.1016/j.ihj.2015.08.009.27316488
  • Ercolini AM, Miller SD. The role of infections in autoimmune disease. Clin Exp Immunol. 2009;155(1):1–15. doi:10.1111/j.1365-2249.2008.03834.x.19076824
  • Strle K, Sulka KB, Pianta A, et al. T- helper 17 cell cytokine responses in lyme disease correlate with borrelia burgdorferi antibodies during early infection and with autoantibodies late in the illness in patients with antibiotic-refractory lyme arthritis. Clin Infect Dis. 2017;64(7):930–938. doi:10.1093/cid/cix002.28077518
  • Grygorczuk S, Chmielewski T, Zajkowska J, et al. Concentration of TGF-beta1 in the supernatant of peripheral blood mononuclear cells cultures from patients with early disseminated and chronic lyme borreliosis. Adv Med Sci. 2007;52:174–178.18217413
  • Chi LJ, Wang HB, Zhang Y, Wang WZ. Abnormality of circulating CD4(+)CD25(+) regulatory T cell in patients with guillain -barré syndrome. J Neuroimmunol. 2007;192(1–2):206–214. doi:10.1016/j.jneuroim.2007.09.034.17997492
  • Maue AC, Mohawk KL, Giles DK, et al. The polysaccharide capsule of campylobacter jejuni modulates the host immune response. Infect Immun. 2013;81(3):665–672. doi:10.1128/IAI.01008-12.23250948
  • Danikowski KM, Jayaraman S, Prabhakar BS. Regulatory T cells in multiple sclerosis and myasthenia gravis. J Neuroinflammation. 2017;14(1):117. doi:10.1186/s12974-017-0892-8.28599652
  • Benagiano M, Munari F, Ciervo A, et al. Chlamydophila pneumoniae phospholipase D (CpPLD) drives Th17 inflammation in human atherosclerosis. Proc Natl Acad Sci U S A. 2012;109(4):1222–1227. doi:10.1073/pnas.1111833109.22232679
  • Shi WJ, Liu W, Zhou XY, Ye F, Zhang GX. Associations of Helicobacter pylori infection and cytotoxin-associated gene A status with autoimmune thyroid diseases: a meta-analysis. Thyroid. 2013;23(10):1294–1300. doi:10.1089/thy.2012.0630.23544831
  • Li C, Yuan J, Zhu YF, et al. Imbalance of Th17/Treg in different subtypes of autoimmune thyroid diseases. Cell Physiol Biochem. 2016;40(1–2):245–252. doi:10.1159/000452541.27855396
  • Bonney KM, Engman DM. Autoimmune pathogenesis of chagas heart disease. Looking back, looking ahead. Am J Pathol. 2015;185(6):1537–1547. doi:10.1016/j.ajpath.2014.12.023.25857229
  • Cai CW, Blasé JR, Eickhoff CS, Hoft DF. Th17 cells confer both systemic and mucosal protection against Trypanosoma cruzi infection. J Immunol. 2017;198(1 Supplement):123.1.
  • Cai CW, Blase JR, Zhang X, Eickhoff CS, Hoft DF. Th17 cells are more protective than Th1 aginst trypanosoma cruzi. PLoS Pathog. 2016;12(10):e1005902. doi:10.1371/journal.ppat.1005902.27695083
  • Kotner J, Tarleton R. EndogenousCD4+ CD25+ regulatory T cells have a limited role in the control of trypanosoma cruzi infection in mice. Infect Immun. 2007;75(2):861–869. doi:10.1128/IAI.01500-06.17101658
  • Flores-García Y, Rosales-Encina JL, Rosales-García VH, Satoskar AR, Talamás-Rohana P. CD4CD25FOXP3 treg cells induced by rSSP4 derived from T. cruzi amastigotes increase parasitemia in an experimental chagas disease model. Biomed Res Int. 2013;2013:632436. doi:10.1155/2013/632436.23509755
  • O’Sullivan BP, Freedman SD. Cyctic fibrosis. Lancet. 2009;373(9678):1891–1904. doi:10.1016/S0140-6736(09)60327-5.19403164
  • Curtis MM, Way SS. Interleukin-17 in host defence against bacterial, mycobacterial and fungal pathogens. Immunology. 2009;126(2):177–185. doi:10.1111/j.1365-2567.2008.03017.x.19125888
  • Hector A, Schäfer H, Pöschel S, et al. Regulatory T-cell impairment in cystic fibrosis patients with chronic pseudomonas infection. Am J Respir Crit Care M Ed. 2015;191(8):914–923. doi:10.1164/rccm.201407-1381OC.
  • Skopelja S, Hamilton BJ, Jones JD, et al. The role for neutrophil extracellular traps in cystic fibrosis autoimmunity. JCI Insight. 2016;1(17). doi:10.1172/jci.insight.88912.
  • Franks A, Slansky JE. Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer. Anticancer Res. 2012;32(4):1119–1136.22493341
  • Saxena V, Lienesch DW, Zhou M, et al. Dual roles of immunoregulatory cytokine TGF-beta in the pathogenesis of autoimmunity-mediated organ damage. J Immunol. 2008;180(3):1903–1912. doi:10.4049/jimmunol.180.3.1903.18209088
  • Anderson LA, Gadalla S, Morton LM, et al. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer. 2009;125(2):398–405. doi:10.1002/ijc.24287.19365835
  • Østgård LSG, Nørgaard M, Pedersen L, et al. Autoimmune diseases, infections, use of antibiotics and the risk of acute myeloid leukaemia: a national population -based case-control study. Br J Haematol. 2018;181(2):205–214. doi:10.1111/bjh.15163.29504124
  • Silano M, Volta U, Mecchia AM, et al. Delayed diagnosis of coeliac disease increases cancer risk. BMC Gastroenterol. 2007;7:8. doi:10.1186/1471-230X-7-8.17349035
  • Chen YK, Lin CL, Chang YJ, et al. Cancer risk in patients with graves’ disease: a nationwide cohort study. Thyroid. 2013;23(7):879–884. doi:10.1089/thy.2012.0568.23421548
  • Turpin J, Yurick D, Khoury G, et al. Impact of hepatitis B virus coinfection on human T-lymphotropic virus Type 1 clonality in an Indigenous population of central australia. J Infect Dis. 2018. doi:10.1093/infdis/jiy546.
  • Vazquez-Guillen JM, Palacios-Saucedo GC, Rivera-Morales LG, et al. Infection and coinfection by human papillomavirus, epstein -barr virus and merkel cell polyomavirus in patients with squamous cell carcinoma of the larynx: a retrospective study. Peer J. 2018;6:e5834. doi:10.7717/peerj.5834.30386708
  • Drop B, Strycharz-Dudziak M, Kliszczewska E, Polz-Dacewicz M. Coinfection with Epstein-Barr Virus (EBV), Human Papilloma Virus (HPV) and Polyoma BK Virus (BKPyV) in laryngeal, oropharyngeal and oral cavity cancer. Int J Mol Sci. 2017;18(12):pii: E2752. doi:10.3390/ijms18122752.
  • Kleinman AJ, Sivanandham R, Pandrea I, et al. Regulatory T cells as potential targets for HIV cure research. Front Immunol. 2018;9:734. doi:10.3389/fimmu.2018.00734.29706961
  • Virot E, Duclos A, Adelaide L, et al. Autoimmune diseases and HIV infection. A cross-sectional study. Medicine (Baltimore). 2017;96(4):e5769. doi:10.1097/MD.000000000000576928121924
  • Gangaplara A, Martens C, Dahlstrom E, et al. Type I interferon signaling attenuates regulatory T cell function in viral infection and in the tumor microenvironment. PLoS Pathog. 2018;14(4):e1006985. doi:10.1371/journal.ppat.1006985.29672594
  • Han S, Toker A, Liu ZQ, Ohashi PS. Turning the tide against regulatory T cells. Front Oncol. 2019;9:279. doi:10.3389/fonc.2019.00279.31058083
  • Gardiner D, Lalezari J, Lawitz E, et al. A randomized, double-blind, placebo-controlled assessment of BMS-936558, a fully human monoclonal antibody to programmed death-1 (PD-1), in patients with chronic hepatitis C virus infection. PLoS One. 2013;8:e63818. doi:10.1371/journal.pone.0063818.23717490
  • Li P, Zheng Y, Chen X. Drugs for autoimmune inflammatory diseases: from small molecule compounds to anti-TNF biologics. Front Pharmacol. 2017;8:460. doi:10.3389/fphar.2017.00460.28785220
  • Bereshchenko O, Coppo M, Bruscoli S, et al. GILZ promotes production of peripherally induced Treg cells and mediates the crosstalk between glucocorticoids and TGF-b signaling. Cell Rep. 2014;7(2):464–475. doi:10.1016/j.celrep.2014.03.004.24703841
  • Aberdein J, Singer M. Clinical review: a systematic review of corticosteroid use in infections. Crit Care. 2006;10(1):203. doi:10.1186/cc3904.16356204
  • Wilhelmus KR, Gee L, Hauck WW, et al. Herpetic Eye Disease Study. A controlled trial of topical corticosteroids for herpes simplex stromal keratitis. Ophthalmology. 1994;101(12):1883–1895. doi:10.1016/s0161-6420(94)31087-6.7997324
  • Pyrrho AS, Lenzi HL, Ramos JA, et al. Dexamethasone treatment improves morphological and hematological parameters in chronic experimental schistosomiasis. Parasitol Res. 2004;92(6):478–483. doi:10.1007/s00436-004-1078-8.14999468
  • McGee S, Hirschmann J. Use of corticosteroids in treating infectious diseases. Arch Intern Med. 2008;168(10):1034–1046. doi:10.1001/archinte.168.10.1034.18504331
  • Niland ML, Bonsu BK, Nuss KE, Goodman DG. A pilot study of 1 versus 3 days of dexamethasone as add-on therapy in children with streptococcal pharyngitis. Pediatr Infect Dis J. 2006;25(6):477–481. doi:10.1097/01.inf.0000219469.95772.3f.16732143
  • McKinley L, Logar AJ, McAllister F, Zheng M, Steele C, Kolls JK. Regulatory T cells dampen pulmonary inflammation and lung injury in an animal model of pneumocystis pneumonia. J Immunol. 2006;177(9):6215–6226. doi:10.4049/jimmunol.177.9.6215.17056551
  • Suvas S, Azkur AK, Kim BS, Kumaraguru U, Rouse BT. CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol. 2004;172(7):4123–4132. doi:10.4049/jimmunol.172.7.4123.15034024
  • Hesse M, Piccirillo CA, Belkaid Y, et al. The pathogenesis of schistosomiasis is controlled by cooperating IL-10- producing innate effector and regulatory T cells. J Immunol. 2004;172(5):3157. doi:10.4049/jimmunol.172.5.3157.14978122
  • Gao A, Shao Y. Investigation for the roles of TLR2, TLR9 and Th17/Treg in the pathogenesis of infectious mononucleosis. Int J Clin Exp Med. 2017;10(10):14946–14953.
  • Lei L, Zhang Y, Yao W, Kaplan MH, Zhou B. Thymic stromal lymphopoietin interferes with airway tolerance by suppressing the generation of antigen-specific regulatory T cells. J Immunol. 2011;186(4):2254–2261. doi:10.4049/jimmunol.1002503.21242516
  • Chen YL, Chiang BL. Targeting TSLP with shRNA alleviates airway inflammation and decreases epithelial CCL17 in a murine model of asthma. Mol Ther Nucleic Acids. 2016;5:e316. doi:10.1038/mtna.2016.29.27138176
  • Ma L, Xue HB, Guan XH, et al. The Imbalance of Th17 cells and CD4(+) CD25(high) Foxp3(+) Treg cells in patients with atopic dermatitis. J Eur Acad Dermatol Venereol. 2014;28(8):1079–1086. doi:10.1111/jdv.12288.24304358
  • Frimpong A, Kusi KA, Tornyigah B, Ofori MF, Ndifon W. Characterization of T cell activation and regulation in children with asymptomatic plasmodium falciparum infection. Malar J. 2018;17(1):263. doi:10.1186/s12936-018-2410-6.30005684
  • Walther M, Tongren JE, Andrews L, et al. Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. Immunity. 2005;23(3):287–296. doi:10.1016/j.immuni.2005.08.006.16169501
  • Gagyor I, Madhok VB, Daly F, et al. Antiviral treatment for Bell’s palsy (idiopathic facial paralysis). Cochrane Database Syst Rev. 2015;(11):CD001869. doi:10.1002/14651858.CD001869.pub8.
  • Pufall MA. Glucocorticoids and cancer. Adv Exp Med Biol. 2015;872:315–333. doi:10.1007/978-1-4939-2895-8_14.26216001
  • Herold MJ, McPherson KG, Reichardt HM. Glucocorticoids in T cell apoptosis and function. Cell Mol Life Sci. 2006;63(1):60–72. doi:10.1007/s00018-005-5390-y.16314919
  • D’Arena G, Vitale C, Coscia M, et al. Regulatory T cells and their prognostic relevance in hematologic malignancies. J Immunol Res. 2017;2017:1832968. doi:10.1155/2017/1832968.29430466
  • Linnebacher M, Maletzki C, Klier U, Klar E. Bacterial immunotherapy of gastrointestinal tumors. Langenbecks Arch Surg. 2012;397(4):557–568. doi:10.1007/s00423-011-0892-6.22189906
  • Zhang H, Diao H, Jia L, et al. Proteus mirabilis inhibits cancer growth and pulmonary metastasis in a mouse breast cancer model. PLoS One. 2017;12(12):e0188960. doi:10.1371/journal.pone.0188960.29206859
  • Staedtke V, Roberts NJ, Bai RY, Zhoua S. Clostridium novyi-NT in cancer therapy. Genes Dis. 2016;3(2):144–152. doi:10.1016/j.gendis.2016.01.003.30258882
  • Behnsen J, Perez-Lopez A, Nuccio SP, Raffatellu M. Exploiting host immunity: the Salmonella paradigm. Trends Immunol. 2015;36(2):112–120. doi:10.1016/j.it.2014.12.003.25582038
  • Linehan JL, Dileepan T, Kashem SW, Kaplan DH, Cleary P, Jenkins MK. Generation of Th17 cells in response to in tranasal infection requires TGF-β1 from dendritic cells and IL-6 from CD301b+ dendritic cells. Proc Natl Acad Sci U S A. 2015;112(41):12782–12787. doi:10.1073/pnas.1513532112.26417101
  • Iqbal NT, Hussain R. Non-specific immunity of BCG vaccine: a perspective of BCG immunotherapy. Trials Vaccinol. 2014;3(C):143–149. doi:10.1016/j.trivac.2014.08.002.
  • Armbruster CE, Mobley HLT, Pearson MM. Pathogenesis of proteus mirabilis infection. EcoSal Plus. 2018;8(1). doi:10.1128/ecosalplus.ESP-0009-2017.
  • Soloski MJ, Metcalf ES. Salmonella as an inducer of autoimmunity. EcoSal Plus. 2007;2(2). doi:10.1128/ecosalplus.8.8.13.
  • Erbinger A, Rashid T. Rheumatoid arthritis is caused by a proteus urinary tract infection. Apmis. 2013;122(5). doi:10.1111/apm.12154.
  • Marwat A, Mehmood H, Hussain A, Khan M, Ullah A, Joshi M. Clostridium difficile colitis leading to reactive arthritis: a rare complication associated with a common disease. J Investig Med High Impact Case Rep. 2018;6:2324709618767689. doi:10.1177/2324709618767689.
  • Chai Q, Zhang Y, Liu CH. Mycobacterium tuberculosis: an adaptable pathogen associated with multiple human diseases. Front Cell Infect Microbiol. 2018;8:158. doi:10.3389/fcimb.2018.00158.29868514
  • Ning S. Innate immune modulation in EBV infection. Herpesviridae. 2011;2(1):1. doi:10.1186/2042-4280-2-1.21429244
  • Getts DR, Chastain EM, Terry RL, Miller SD. Virus infection, antiviral immunity, and autoimmunity. Immunol Rev. 2013;255(1):197–209. doi:10.1111/imr.12091.23947356
  • Yu XL, Cheng YM, Shi BS, et al. Measles virus infection in adults induces production of IL-10 and is associated with increased CD4+ CD25+ regulatory T cells. J Immunol. 2008;181(10):7356–7366. doi:10.4049/jimmunol.181.10.7356.18981159
  • Yu W, Geng S, Suo Y, et al. Critical role of regulatory T cells in the latency and stress-induced reactivation of HSV-1. Cell Rep. 2018;25(9):2379–2389.e3. doi:10.1016/j.celrep.2018.10.105.30485807
  • Smyk DS, Koutsoumpas AL, Mytilinaiou MG, Rigopoulou EI, Sakkas LI, Bogdanos DP. Helicobacter pylori and autoimmune disease: cause or bystander. World J Gastroenterol. 2014;20(3):613–629. doi:10.3748/wjg.v20.i3.613.24574735
  • Boer CM, Joosten SA, Ottenhoff THM.Regulatory T-cells at the interface between human host and pathogens in infectious diseases and vaccination. Front Immunol.2015;6:217. doi:10.3389/fimmu.2015.00217. doi:10.3389/fimmu.2015.00217.26029205
  • Chen P, Wang M, Li D, et al. The alteration and clinical significance of Th22/Th17/Th1 cells in patients with chronic m yeloid leukemia. J Immunol Res. 2015;2015:416123. doi:10.1155/2015/416123.26000313
  • Cheng Y, Yang GO, Sun M, Chang K, Long R, Jiang Z. The expression and clinical significance of Treg cells in chronic myeloid leukemia. Biomed Res. 2017;28(21):9188–9192.